Literature DB >> 3141518

Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.

R G Masterton1, E R Youngs, J C Wardle, K F Croft, D M Jones.   

Abstract

An outbreak of meningitis in Royal Air Force recruits due to Neisseria meningitidis Group C type PI, 2 gave the first opportunity for polysaccharide vaccine to be used for controlling such an outbreak in the U.K. The effect of the vaccine on an epidemic in a large recruit training centre was studied after chemoprophylaxis had failed. With the possible exception of one vaccinee, further cases did not arise among camp personnel. Vaccination was continued until the carriage rate of the epidemic strain among recruits leaving the camp had fallen from greater than 19 to less than 1%. Two persons who had only indirect contact with the camp developed the disease. Vaccination early in the course of such an outbreak appears to be a useful and practical method of limiting symptomatic infection but not acquisition of the epidemic strain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141518     DOI: 10.1016/s0163-4453(88)91907-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Preventative strategies on meningococcal disease.

Authors:  R T Mayon-White; P T Heath
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 2.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Authors:  R Almog; C Block; M Gdalevich; B Lev; M Wiener; S Ashkenazi
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

Review 4.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

5.  Mass vaccination campaign following community outbreak of meningococcal disease.

Authors:  Gérard Krause; Carina Blackmore; Steven Wiersma; Cheryll Lesneski; Laurey Gauch; Richard S Hopkins
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.